Introduction
Hematopoietic stem (HSCs) and progenitor (HPCs) cells, which give rise to all blood cells, have been used to practical advantage for treating blood cell systems compromised by genetic disease, cancer, and chemotherapy.
1,2 A better understanding of HSC/HPC regulation would enhance HSC/HPC transplantation and disease treatment. Proteins on the surface of HSCs/HPCs, such as Sca1, CD34, CD90, CD150, and CD48 have been used to identify and purify these cells, 3 but little is known of the possible roles of these cell surface markers in regulating HSC/HPC functions. MHC class I and II antigens on HSCs/HPCs, which are crucial for matching of donor cells with recipients for optimal HSC transplantation, have in only limited situations been linked to responsiveness of HPC to regulatory cytokines/chemokines. [4] [5] [6] Based on our previous studies that demonstrated a role for both NKT cells and CD1d 7 on hematopoietic effects in mice infected with cytomegalovirus, and that linked cells of the immune system to regulation of hematopoiesis, [8] [9] [10] [11] [12] along with our interest in CD1d-NKT cell interactions under normal conditions and in several different disease models, [13] [14] [15] we evaluated the expression of CD1d on HSCs and HPCs. After identifying this expression, we tested the hypothesis that cell surface expression of CD1d on HSCs and HPCs plays a regulatory role in their proliferation and engraftment. Our findings suggest novel and previously unrecognized roles for CD1d in the regulation of hematopoiesis.
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HPC Colony Assays and HSC Engrafting Studies. Numbers of HPC per femur or spleen, and % HPC in cycle (S-Phase of cell cycle) were performed and calculated as reported. 23, 24 Competitive and non-competitive engraftment of lethally-irradiated primary, and non-competitive engraftment of lethally-irradiated secondary, congenic mouse recipients were done as reported.
23,24
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For personal use only. on October 4, 2017. by guest www.bloodjournal.org From Results i) CD1d-/-mice under steady-state conditions manifest enhanced HPC numbers and proliferation. Towards the possibility that CD1d might be involved in the regulation of hematopoiesis, we analyzed numbers of myeloid progenitor cells and their proliferation status in femoral BM and spleens of CD1d -/-(cd1d1-/-) mice compared to that of control mice. As seen in Figure 1A and B, the absolute numbers of granulocyte-macrophage (CFU-GM), erythroid (BFU-E), and multi-potential (CFU-GEMM) progenitors in BM and spleen of CD1d -/-mice were significantly higher than in the control mice. This observation was reproducible in CD1d-/-mice on either a C57Bl/6 16 ( Fig. 1A) or Balb/c (Fig. 1B ) mouse strain background, and on BM cells from a completely different CD1d knockout mouse (cd1d1 and cd1d2 deletion 17 ) on a C57Bl/6 background ( Fig. 2C and D) ,
suggesting that effects were not due to mouse strain or genetic -/-background differences. That this was due to increased proliferation of the myeloid progenitors in BM and spleen is apparent from the results in Figure 1C (C57Bl/6 mice), 1D (Balb/c mice), and demonstrates an approximately two-fold increase in cycling of HPCs in the BM of CD1d -/-mice compared to that in the +/+ mice. HPCs in the spleen of normal mice are usually in a slow or non-cycling state, as is the case here, and this cycling rate was greatly enhanced in the spleens of CD1d -/-mice for the two different mouse strains ( Fig. 1C and 1D ). That enhanced hematopoiesis noted at the HPC level in CD1d-/-mice was not a reflection of Type 1 NKT cell effects was shown in additional experiments. CD1d-/-mice are deficient in both type I and type II NKT cells. 25 However, Jα18-/-mice, which are deficient in Type I NKT cells but which express normal levels of CD1d, demonstrated normal absolute numbers ( Figure 2A ) and cycling ( Figure 2B ) of HPCs in BM and spleen of C57Bl/6 mice, and in BM of Balb/c mice ( Fig. 2C and 2D ). Thus, CD1d expression acts in a negative manner to control proliferation of HPCs in mice, reflecting either direct effects through CD1d on myeloid progenitors and/or indirect effects perhaps mediated through CD1d expressing accessory cells.
However, it does not reflect Type I NKT cell activity and instead suggests a role for Type II NKT cells or CD1d in the observed effects. We evaluated expression of CD1d on HSCs and HPCs in BM of +/+ mice. As seen in Figure 2E , most CFU-GM, BFU-E and CFU-GEMM, defined here as immature subsets of these cells because they were stimulated in vitro by multiple growth factors, 2, 25 sorted into the CD1d + population of cells.
These results suggested that the effects seen on HPC numbers and cycling status in the CD1d -/-mice ( Figure   1A -D and Figure 2A -D) might reflect, at least in part, direct effects involving expression of CD1d on HPC.
iii) Anti-CD1d stimulation increases numbers of BM myeloid progenitor cell-derived colonies in vitro.
To determine if blocking CD1d would influence colony formation by myeloid progenitor cells in vitro, unseparated mouse BM cells were pre-incubated in suspension culture with either control medium, isotype control antibodies (Ab), or CD1d-specific antibodies, and the cells plated in either methylcellulose culture medium in the presence of Epo, PWMSCM, SCF and hemin to determine effects on immature subsets of CFU-GM, BFU-E or CFU-GEMM, or in agar culture medium with either GM-CSF, IL-3 or M-CSF for respective assessment of mature subsets of GM-CSF-responsive CFU-GM, IL-3 responsive CFU-GM, or M-CSF responsive macrophage progenitors (CFU-M: Colony Forming Unit-Macrophage). As shown in Figure 3A , treatment of unseparated BM cells in vitro with a CD1d-specific (1H6) antibody significantly increased numbers of cytokine-stimulated immature CFU-GM-, BFU-E-and CFU-GEMM-derived colonies, as well as
For personal use only. on October 4, 2017. by guest www.bloodjournal.org From more mature populations of CFU-GM-and CFU-M-derived colonies. This anti-CD1d mediated enhancement in proliferation of immature subsets of CFU-GM, BFU-E and CFU-GEMM ( Figure 3A) , and mature subsets of CFU-GM and CFU-M (data not shown), was seen with control (+/+) BM cells, but not with BM cells from CD1d -/-mice ( Figure 3B ). No colonies of any type formed in the absence of CSFs or other growth factors, whether or not anti-CD1d antibodies were present (Data not shown). The proliferation enhancing effects of a number of different CD1d-specific antibodies on BM CFU-GM from both wildtype C57Bl/6 and Balb/c mice, but not on C57Bl/6 or Balb/c CD1d-/-cells are seen in Figure 3C . Of note, the anti-CD1d antibodies enhanced colony formation of HPCs from Jα18-/-mice which express CD1d, but lack Type I NKT cells ( Figure 3C ). The cytoplasmic domain of CD1d is involved in intracellular signaling mediated through activation of CD1d, 40, 41 and multiple defects in antigen presentation and T cell development are apparent in mice expressing cytoplasmic tail-truncated CD1d. 19 These latter effects were identified through the use of mice in which the CD1d cytoplasmic tail deletion was knocked into CD1d -/-mice. 19 We assessed a role for the cytoplasmic tail were also similar to WT control mice in terms of absolute numbers and cycling status of HPC in the spleen (Figure 5Ci and ii). Additionally, BM CFU-GM, BFU-E, and CFU-GEMM from CD1d knock-in mice responded exactly as these progenitors from WT control mice to synergistic stimulation by the combinations of GM-CSF or IL-3 with either FL or SCF ( Figure 5D ), and to inhibition by selected myelosuppressive chemokines ( Figure 5E ). The C-terminal CD1d cytoplasmic domain sequence removed for the knock-in mice was SAYQDIR, with only 3 membrane proximal Rs left for the entire intracytoplasmic region after this deletion. 19 Thus, the last 7 amino acids (SAYQDIR) of the cytoplasmic tail of CD1d is necessary for CD1d For personal use only. on October 4, 2017. by guest www.bloodjournal.org From secondary mice is a measure of the long-term repopulating ability and self-renewal capacity of HSCs. Thus, these studies suggest a modest decreased number and/or self-renewal capacity of long-term repopulating CD1d -/-HSCs. Since stimulation of +/+ marrow cells with CD1d antibodies enhances colony formation of HPCs (Figure 3) , we also evaluated effects of pre-treating bone marrow cells in vitro with anti-CD1d or isotype control antibody prior to assessing primary and secondary engrafting capability of HSC in these treated cell preparations. As seen in Figure 6D , pretreatment of HSCs in a mixed population of cells in vitro with antiCD1d enhanced the engrafting capability of HSC in the primary mice, an enhancement even more apparent in the secondary in vivo repopulation studies. Together, the studies in Figure 6 suggest a role for CD1d on longterm repopulating HSC engraftment and repopulation of lethally irradiated mouse recipients.
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